Quarterly earnings reports are supposed to be about a public company's financial health, but during today's call, Apple's institutional investors want a checkup on CEO Steve Jobs. They haven't gotten over Jobs's overly thin appearance at WWDC in June. "Apple's hedge-fund investors are very worried," a Wall Street source tells the New York Post. In the weeks following WWDC, Apple told reporters Jobs looked so ill because of antibiotic treatments for a cold.

But Jobs's health hasn't seemed to improve since, according the Post, which cites "multiple sources who have met with — and in some cases even dined with — Jobs in the weeks surrounding the introduction of the iPhone 3G on July 11." (Gossipy gadget reviewers, perchance?) Jobs, a Disney director, recently attended a board meeting there, and his health dominated the gossip afterward. It's all got investors feeling shaky about a company that otherwise looks strong. One investor even told the Post he sold down stake in Apple due to Jobs's health. Just by "a few million shares," though.

Contact information for this author is not available.